VEON (Buy, TP: $65/ADR, +24%) Q2 25: Tracking well, guidance lifted
VEON delivered another round of decent growth across almost all geographies, driving 6% revenue growth and 13% EBITDA growth in US$. As a result, it lifted local currency revenue and EBITDA guidance by 1%, a function of the acquisition of Uklon rather than underlying upgrades.
Provided by our team of experienced analysts, our work is idea driven, based on independence of thought, sector expertise, and firmly focussed on fundamentals and valuation.
New Street Research is an independent, partner-owned, research firm specialising in equity and debt research. Our equity research embraces the following sectors:
- Pan European Telecom Services and Cable
- US Telecoms, Cable, Satellite and Towers
- Global Emerging Market Telecoms
- Japan Telecoms
- Asian Internet
- Pan European Healthcare
- Global healthcare thematic research
We provide debt research on:
- Pan European Telecom Services and Cable
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.